Earnings History Data for I-MAB (IMAB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

I-MAB

I-Mab is a clinical stage biopharmaceutical company. It engages in discovery, development and commercialization of biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. I-Mab is based in SHANGHAI, China.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-11-2024	PM		IMAB	I-MAB	85.54	-0.25	-0.16	0.00	I-Mab Biopharma GAAP EPS of -$0.11 misses by $0.04 [11/14/2024 7:05 AM]	1.09	0.05 (4.81%)	1.10	0.06 (5.77%)	0.99 - 2.54	299,845	340,000	20,847
I-Mab Biopharma GAAP EPS of -$0.11 misses by $0.04 [11/14/2024 7:05 AM] I-Mab Reports Third Quarter 2024 Results [2024-11-14 07:00AM]
28-08-2024	PM		IMAB	I-MAB	104.91	-0.07	-0.51	0.00	I-Mab Biopharma GAAP EPADS of -$0.09 beats by $0.13 [8/28/2024 7:10 AM]	1.17	-0.09 (-7.14%)	1.31	0.05 (3.97%)	0.99 - 2.54	234,925	230,000	19,961
I-Mab Biopharma 1H Earnings Preview [8/27/2024 1:50 PM] I-Mab Biopharma GAAP EPADS of -$0.09 beats by $0.13 [8/28/2024 7:10 AM]
17-08-2023	PM		IMAB	I-MAB	198.35	N/A	0.00	0.00	I-Mab Biopharma Non-GAAP EPADS of -$1.05 misses by $0.26, revenue of $2.7M misses by $0.3M [8/17/2023 6:16 AM]	2.31	-0.06 (-2.74%)	2.52	0.15 (6.33%)	2.24 - 7.67	558,226	350,000	20,030
I-Mab Biopharma 1H 2023 Earnings Preview [8/16/2023 2:34 PM] I-Mab Biopharma Non-GAAP EPADS of -$1.05 misses by $0.26, revenue of $2.7M misses by $0.3M [8/17/2023 6:16 AM]
31-03-2023	PM	7:00 AM ET (Mar 31)	IMAB	I-MAB	365.63	N/A	0.00	0.00	I-Mab Biopharma Non-GAAP EPADS of -$3.58 misses by $2.75, revenue of $32.1M misses by $69.23M [3/31/2023 6:43 AM]	3.42	-0.10 (-2.84%)	3.55	0.03 (0.85%)	2.73 - 19.11	933,679	610,000	3,466
I-Mab Biopharma FY 2022 Earnings Preview [3/30/2023 12:47 PM] I-Mab Biopharma Non-GAAP EPADS of -$3.58 misses by $2.75, revenue of $32.1M misses by $69.23M [3/31/2023 6:43 AM]
29-03-2022	PM	7:00 AM ET (Mar 29)	IMAB	I-MAB	1,420	N/A	-1.33	0.00	I-Mab Biopharma Non-GAAP EPS of -$1.54 misses by $0.63, revenue of $13.8M misses by $70.64M [3/29/2022 6:17 AM]	19.32	2.47 (14.66%)	16.71	-0.14 (-0.83%)	12.00 - 85.40	742,349	1,250,000	4,931
I-Mab Biopharma Non-GAAP EPS of -$1.54 misses by $0.63, revenue of $13.8M misses by $70.64M [3/29/2022 6:17 AM] I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2021 [Mar-29-22 06:10AM]
29-03-2021	PM	7:00 AM ET (Mar 29)	IMAB	I-MAB	3,790	N/A	0.39	-17.05	I-Mab Biopharma EPS beats by $0.09, beats on revenue [3/29/2021 7:30 AM]	44.45	-2.17 (-4.65%)	47.09	0.47 (1.01%)	12.15 - 65.94	554,764	410,000	7,045
I-Mab Biopharma EPS beats by $0.09, beats on revenue [3/29/2021 7:30 AM] I-Mab Reports Financial Results for Full Year of 2020 and Provides Business Updates [Mar-29-21 07:00AM] IMab ADR (IMAB) Q4 2020 Earnings Call Transcript [Mar-29-21 04:00PM]